Bortezomib and pegylated liposomal doxorubicin as induction therapy for adult patients with symptomatic multiple myeloma: Cancer and Leukemia Group B study 10301.
Meeting Abstract
Orlowski, Robert Z., Peterson, Bercedis L., Sanford, Ben, Chanan-Khan, Asher A., Zehngebot, Lee M., Watson, Peter R., Caligiuri, Michael A., Larson, Richard A., Cancer and Leukemia Grp B